| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/18/2013 | CN103446546A Capsule for eliminating illness and removing stasis and preparation method thereof |
| 12/18/2013 | CN103446540A Pure Chinese medicine composition for treating chicken reticuloendotheliosis and preparation method thereof |
| 12/18/2013 | CN103446539A Chinese medicine pills for treating breast cancers |
| 12/18/2013 | CN103446511A Oral sharpleaf galangal fruit solution |
| 12/18/2013 | CN103446492A Selenium butyric acid inclusion agent and preparation method thereof |
| 12/18/2013 | CN103446459A Traditional Chinese medicine pill for treating intracranial tumor-induced epilepsy |
| 12/18/2013 | CN103446449A Rhizoma fagopyri cymosi powerful immune capsule |
| 12/18/2013 | CN103446248A Lotus root plant total extract-containing dripping pills and preparation method thereof |
| 12/18/2013 | CN103446211A Cynanchum komarovii total alkaloid and preparing method and application thereof |
| 12/18/2013 | CN103446207A Preparation method and application of reagent for activating human immune cells |
| 12/18/2013 | CN103446206A Composition for improving toxic and side effects caused by chemotherapy on malignant tumor patient and application thereof |
| 12/18/2013 | CN103446195A Preparation method of ginkgo biloba extract |
| 12/18/2013 | CN103446194A Anti-cancer oral medicine prepared from Chinese yew extract |
| 12/18/2013 | CN103446193A Anticancer drug taking Chinese yew essential oil as main raw material |
| 12/18/2013 | CN103446192A Soft capsule for inhibiting canceration |
| 12/18/2013 | CN103446191A Freeze-drying method capable of remarkably improving quality of fermentative cordyceps sinensis mycelia |
| 12/18/2013 | CN103446162A Applications of 3 beta, 20(s), 21-trihydroxydammarane-24-alkene on preparation of tumor multi-drug resistance (MDR) reversing agents |
| 12/18/2013 | CN103446155A mTOR (Mammalian Target Of Rapamycin) inhibitor and use thereof |
| 12/18/2013 | CN103446150A Application of Lycojaponicumin C in liver cancer treatment drug |
| 12/18/2013 | CN103446146A Application of Lycojaponicumin C in ileocecum cancer treatment drug |
| 12/18/2013 | CN103446144A Application of Lycojaponicumin C in biliary duct cancer treatment drug |
| 12/18/2013 | CN103446143A Application of Lycojaponicumin C in gastric cancer treatment drug |
| 12/18/2013 | CN103446142A Application of Lycojaponicumin C in pancreatic cancer treatment drug |
| 12/18/2013 | CN103446141A Application of Lycojaponicumin C in tongue cancer treatment drug |
| 12/18/2013 | CN103446138A Neuroendocrine tumor treatment using mtor inhibitors |
| 12/18/2013 | CN103446136A Application of Lycojaponicumin A in anti-lung cancer metastasis drug |
| 12/18/2013 | CN103446134A Application of Lycojaponicumin A in leukemia treatment drug |
| 12/18/2013 | CN103446133A Application of Lycojaponicumin B in tongue cancer treatment drug |
| 12/18/2013 | CN103446130A Application of Lycojaponicumin B in liver cancer treatment drug |
| 12/18/2013 | CN103446128A Application of Lycojaponicumin B in skin cancer treatment drug |
| 12/18/2013 | CN103446123A Application of Lycojaponicumin B in colorectal cancer treatment drug |
| 12/18/2013 | CN103446122A Application of Lycojaponicumin B in prostate cancer treatment drug |
| 12/18/2013 | CN103446101A Application of Chukrasone B in medicament for treating liver cancer |
| 12/18/2013 | CN103446100A Arctigenin sublingual preparation |
| 12/18/2013 | CN103446099A Applications of icaritin in preparing medicament for preventing and treating alzheimer disease |
| 12/18/2013 | CN103446092A Application of Incarviatone A in cervical cancer treatment drug |
| 12/18/2013 | CN103446091A Application of Incarviatone A in laryngeal cancer treatment drug |
| 12/18/2013 | CN103446089A Application of Incarviatone A in nasopharynx cancer treatment drug |
| 12/18/2013 | CN103446088A Application of Incarviatone A in skin cancer treatment drug |
| 12/18/2013 | CN103446087A Application of Incarviatone A in endometrial cancer treatment drug |
| 12/18/2013 | CN103446086A Application of Incarviatone A in gastric cancer treatment drug |
| 12/18/2013 | CN103446084A Application of Incarviatone A in pancreatic cancer treatment drug |
| 12/18/2013 | CN103446083A Application of aplysin in preparation of medicine for treating glioma |
| 12/18/2013 | CN103446079A Application of Bostrycin to preparation of protein tyrodine phosphatase (PTP) bonding agents or inhibitors |
| 12/18/2013 | CN103446076A Allyl isothiocyanate solid lipid nanoparticle and preparation method thereof |
| 12/18/2013 | CN103446069A Oral solid composition of abiraterone and preparation method thereof |
| 12/18/2013 | CN103446068A Bortezomib freeze-dried composition and preparation method thereof |
| 12/18/2013 | CN103446060A Docetaxel polydroxybutyrate nanoparticle, manufacturing method and pisum sativum agglutinin modification method and application |
| 12/18/2013 | CN103446057A Oral curcumin nano-granule and preparation method thereof |
| 12/18/2013 | CN103446055A Preparation method for genistein lipid nano body |
| 12/18/2013 | CN103446054A Liposome combination drugs, industrial production process of liposome combination drug through molecular dispersion method, and quality control |
| 12/18/2013 | CN103446053A Targeting liposome drug delivery system for multidrug resistant tumors |
| 12/18/2013 | CN103446050A Preparation method of allyl isothiocyanate micelle preparation |
| 12/18/2013 | CN103446045A Stable busulfan injection |
| 12/18/2013 | CN103446042A Medicinal preparation having taxus canadensis marsh |
| 12/18/2013 | CN103446041A Leuprorelin slow-controlled drug release stick and preparation method thereof |
| 12/18/2013 | CN103446040A Docetaxel-coated polymeric micelle and preparation method thereof |
| 12/18/2013 | CN103445068A Preparation method of barley extract fermented by lactobacillus and anti-tumor effect of barley extract fermented by lactobacillus |
| 12/18/2013 | CN103027986B Traditional Chinese medicine ointment for treating tumors |
| 12/18/2013 | CN103007084B Preparation method of traditional Chinese medicine for treating liver cancer |
| 12/18/2013 | CN102942514B Ionone keto-double-chalcone thiosemicarbazone and production method thereof |
| 12/18/2013 | CN102920977B Traditional Chinese medicine composition for treating liver cancer |
| 12/18/2013 | CN102908466B Propolis dropping pills and preparation method thereof |
| 12/18/2013 | CN102872139B Application of Houttuynoid C in drug for treating tongue cancer |
| 12/18/2013 | CN102872072B Application of Houttuynoid B to preparing drugs for treating kidney cancer |
| 12/18/2013 | CN102861097B Application of Houttuynoid E in medicine for treating bladder cancer |
| 12/18/2013 | CN102861094B Application of Houttuynoid E in medicine for treating bile duct cancer |
| 12/18/2013 | CN102861071B Application of Houttuynoid A in medicine for treating gastric cancer |
| 12/18/2013 | CN102824398B Application of sedum purpureum for preparation of pharmaceuticals for treating tumors |
| 12/18/2013 | CN102813774B Traditional Chinese medicine combination for treating stony goiter and preparation method thereof |
| 12/18/2013 | CN102764315B Medicine for treating goiter |
| 12/18/2013 | CN102757482B Polypeptide and application thereof |
| 12/18/2013 | CN102746380B Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis |
| 12/18/2013 | CN102727906B Clathrates of N-methyl-4-(4-(3-trifluoromethyl)benzoylamino)phenoxyl)nicotinamide and salt thereof, preparation method thereof, and application thereof |
| 12/18/2013 | CN102716491B Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same |
| 12/18/2013 | CN102614529B Drug delivery system for treating nasopharyngeal carcinoma (NPC) and construction method and application method thereof |
| 12/18/2013 | CN102603769B Sulfur-containing chromone compound and preparation method thereof and application in preparation of antitumor drugs |
| 12/18/2013 | CN102600250B In-situ gel sustained-release preparation of Ranunculus ternatus Thunb., and its preparation method |
| 12/18/2013 | CN102552619B Medicine for treating tumor and preparation method thereof |
| 12/18/2013 | CN102532268B Oligopeptide with breast cancer resistant activity and application thereof |
| 12/18/2013 | CN102504039B Extraction process of black corn silk polysaccharide |
| 12/18/2013 | CN102481334B Prodrug Anti-cancer Therapy |
| 12/18/2013 | CN102432624B Preparation technology for crystal of dithiole pyrrolones compound |
| 12/18/2013 | CN102429951B Flavone-saponin extract of humifuse euphorbia herb and application thereof |
| 12/18/2013 | CN102397593B Embolization particles developable under X-rays and preparation method and application thereof |
| 12/18/2013 | CN102335435B Multifunctional polyurethane medicament carrier as well as preparation method and application thereof |
| 12/18/2013 | CN102307852B Cyclic amine compounds |
| 12/18/2013 | CN102283867B Traditional Chinese medicine composition for treating cancer |
| 12/18/2013 | CN102234266B Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure |
| 12/18/2013 | CN102228698B HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof |
| 12/18/2013 | CN102212556B Recombinant adeno-associated virus vector of tumour-targeted double genes |
| 12/18/2013 | CN102143958B Pyridazine derivatives as SMO inhibitors |
| 12/18/2013 | CN101903374B 2-benzylpyridazinone derivatives as MET kinase inhibitors |
| 12/18/2013 | CN101857589B Pyrazol-benzimidazoles derivative and application thereof |
| 12/18/2013 | CN101857554B Cinamic compounds and derivatives therefrom for inhibition of histone deacetylase |
| 12/18/2013 | CN101821383B Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on large scale, primary mesenchymal stem cells obtained by method, uses thereof |
| 12/18/2013 | CN101641014B Inhibitors of poly(ADP-ribose)polymerase |
| 12/18/2013 | CN101410387B Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 12/18/2013 | CN101333244B Protein purification by ion exchange chromatography |
| 12/17/2013 | US8609725 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |